Antigen specificity of dual reactive T hybridomas determines the requirement for CD40 ligand CD40 interactions

被引:0
|
作者
Ozaki, ME [1 ]
Karlsson, L [1 ]
Peterson, PA [1 ]
Webb, SR [1 ]
机构
[1] SCRIPPS RES INST, DEPT IMMUNOL, IMM4, LA JOLLA, CA 92037 USA
来源
JOURNAL OF IMMUNOLOGY | 1997年 / 159卷 / 01期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD40 ligand (CD40L) expression on T cells is known to play a crucial role in B cell responses, Some evidence also supports a role for CD40L-CD40 interactions in T cell responses, at least in vivo. Whether the T cell requirement for these interactions is an invariable finding, however, is less clear. Here, we provide evidence that the Ag specificity of T cells influences the requirement for CD40L. T cell hybridomas with dual reactivity for two different Ags, allo-H2-A(p) and Mls(a) superantigens, display a differential requirement for CD40L expression. Whereas the response to splenic APC expressing Mls(a) Ags requires CD40L expression, the response to alloantigen-bearing APC does not. The requirement for CD40L expression for the Mls(a) response appears to reflect a strong dependence of this response on ICAM-1 (intercellular adhesion molecule-1) and the ability of CD40-mediated signals to regulate ICAM-1 expression. These findings demonstrate that CD40L-CD40-mediated cross-talk is important for some but not all T cell responses and is influenced by both the type of Ag recognized and the type of APC.
引用
收藏
页码:214 / 221
页数:8
相关论文
共 50 条
  • [21] CD40/CD40 ligand interactions are critical for elicitation of autoimmune-mediated fibrosis in the lung
    Zhang-Hoover, J
    Sutton, A
    Stein-Streilein, J
    JOURNAL OF IMMUNOLOGY, 2001, 166 (05): : 3556 - 3563
  • [22] The CD40/CD40 ligand interaction is required for resistance to toxoplasmic encephalitis
    Reichmann, G
    Walker, W
    Villegas, EN
    Craig, L
    Cai, GF
    Alexander, J
    Hunter, CA
    INFECTION AND IMMUNITY, 2000, 68 (03) : 1312 - 1318
  • [23] Clustering of CD40 ligand is required to form a functional contact with CD40
    Grassmé, H
    Bock, J
    Kun, J
    Gulbins, E
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (33) : 30289 - 30299
  • [24] CD40 Ligand Deficiency
    Leite, L. F. B.
    Maximo, T. A.
    Mosca, T.
    Forte, W. C. N.
    ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2020, 48 (04) : 409 - 413
  • [25] CD40 ligand blockade
    Frances Williams
    Arthritis Research & Therapy, 3 (1)
  • [26] Resting B lymphocytes as APC for naive T lymphocytes: Dependence on CD40 ligand/CD40
    Evans, DE
    Munks, MW
    Purkerson, JM
    Parker, DC
    JOURNAL OF IMMUNOLOGY, 2000, 164 (02): : 688 - 697
  • [27] Coexpression of CD40 and CD40 ligand in cutaneous T-cell lymphoma (mycosis fungoides)
    Storz, M
    Zepter, K
    Kamarashev, J
    Dummer, R
    Burg, G
    Häffner, AC
    CANCER RESEARCH, 2001, 61 (02) : 452 - 454
  • [28] Upregulation of CD40 and CD40 ligand (CD154) in patients with moderate hypercholesterolemia
    Garlichs, CD
    John, S
    Schmeisser, A
    Eskafi, S
    Stumpf, C
    Karl, M
    Goppelt-Struebe, M
    Schmieder, R
    Daniel, WG
    CIRCULATION, 2001, 104 (20) : 2395 - 2400
  • [29] CD30/CD30 ligand and CD40/CD40 ligand in malignant lymphoid disorders
    Younes, A
    Carbone, A
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 1999, 14 (03): : 135 - 143
  • [30] A polymorphic CD40 Ligand (CD154) molecule mediates CD40-dependent signalling but interferes with the ability of soluble CD40 to functionally block CD154:CD40 interactions
    Barnhart, B
    Ford, GS
    Bhushan, A
    Song, C
    Covey, LR
    IMMUNOLOGY, 2000, 99 (01) : 54 - 61